Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
In Vivo CAR-T-Mimicking Cells Enabled by Magnetic Nano-Antib
2026-06-29
This study presents a magnetic bispecific nano-antibody (M-BiNanoAb) system for in vivo generation and directed migration of CAR-T-mimicking cells, overcoming persistent barriers in solid tumor immunotherapy. The approach leverages magnetic navigation and bispecific targeting to enhance T cell activation and tumor infiltration, demonstrating potent antitumor effects in preclinical models.
-
EPZ5676: Potent DOT1L Inhibitor for MLL Leukemia Research
2026-06-29
EPZ5676 is a highly selective DOT1L inhibitor with nanomolar potency, demonstrating over 37,000-fold selectivity versus related enzymes. It effectively inhibits H3K79 methylation and suppresses MLL-fusion target genes, showing robust activity in acute leukemia models. These attributes make EPZ5676 a benchmark tool for investigating epigenetic regulation in MLL-rearranged leukemia.
-
KAS-ATAC Sequencing: Mapping Accessible and ssDNA-Containing
2026-06-28
The referenced study introduces KAS-ATAC sequencing, a protocol that enables high-resolution mapping of genomic regions that are both physically accessible and contain single-stranded DNA (ssDNA) elements. By combining N3-kethoxal labeling with ATAC-seq principles, this method advances the precision of chromatin and transcriptional regulation mapping, facilitating deeper understanding of gene expression mechanisms.
-
Charge-Reversed Exosomes Enable Targeted mRNA Delivery to Ca
2026-06-27
This study introduces charge-reversed, cationic exosomes engineered to efficiently deliver mRNA to chondrocytes deep within osteoarthritic cartilage. By overcoming cartilage's dense, anionic barrier, this non-viral platform expands the potential for targeted gene therapy in osteoarthritis.
-
Prostaglandin E2 (PGE2): Mechanisms, Evidence, and Research
2026-06-26
Prostaglandin E2 (PGE2) is a potent lipid-derived autacoid central to immune regulation, inflammation research, and gastrointestinal mucosal protection. Its precise receptor selectivity and verified solubility profiles make it a key tool in advanced experimental systems. This article provides atomic, referenced facts on PGE2's mechanisms, benchmarks, and optimal laboratory integration.
-
EGTA for Precision Calcium Chelation in Neuroprotection Mode
2026-06-26
EGTA (egtaizic acid) delivers highly selective calcium chelation, empowering researchers to dissect calcium-dependent pathways in neurodegeneration and synaptic physiology. This guide details workflow enhancements, troubleshooting, and data-driven protocol parameters for robust, reproducible calcium signaling studies using APExBIO’s high-purity EGTA.
-
One-step TUNEL FITC Apoptosis Kit: Precision in Vascular Rem
2026-06-25
Explore how the One-step TUNEL FITC Apoptosis Detection Kit enables high-precision apoptosis detection in pulmonary vascular remodeling research—offering distinct workflow and scientific insights for advanced tissue and cell-based studies.
-
CRISPRi-Driven Fabp4 Silencing in Adipocytes Ameliorates Obe
2026-06-25
This study introduces a targeted CRISPR interference system delivered specifically to white adipocytes to suppress Fabp4, leading to significant improvement in obesity and related metabolic disorders in mice. The findings highlight the therapeutic potential of precision gene regulation approaches for metabolic syndrome and offer a benchmark for future small-molecule and gene-targeting strategies.
-
Applied Use of α-Linolenic Acid in Lipid Metabolism Studies
2026-06-24
Harnessing α-Linolenic Acid (ALA) from APExBIO enables rigorous and reproducible lipid metabolism, cardiovascular, and immunometabolism research across in vitro and in vivo models. This guide delivers protocol optimization, troubleshooting, and cross-domain insight, anchored by the latest evidence on polyunsaturated fatty acid-driven immune modulation.
-
Reliable Probe Synthesis with HyperScribe™ T7 High Yield Cy3
2026-06-23
This article explores real-world laboratory challenges in fluorescent RNA probe generation and demonstrates how the HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit (SKU K1061) delivers high-yield, reproducible solutions. Scenario-driven Q&A blocks address probe optimization, workflow compatibility, and product reliability—empowering life science researchers to achieve robust, quantitative results.
-
Oligo (dT) 25 Beads: Driving Next-Gen mRNA Isolation
2026-06-23
This thought-leadership article examines the mechanistic foundation and translational significance of Oligo (dT) 25 Beads for eukaryotic mRNA isolation. Integrating recent multiomics findings in animal science, we provide strategic guidance for researchers seeking high-integrity, scalable purification workflows, and highlight how APExBIO's solution addresses challenges from bench to bedside.
-
Dimethyloxalylglycine (DMOG): Technical Guide for Research U
2026-06-22
Dimethyloxalylglycine (DMOG) provides a controlled, reversible approach to stabilize hypoxia-inducible factor (HIF) in vitro and in vivo, enabling investigation of hypoxic signaling and related immune processes. It is intended solely for research applications and should not be used in diagnostic or therapeutic workflows.
-
BipD-Mediated Mitophagy: A New Bacterial Evasion Mechanism
2026-06-22
This study uncovers how Burkholderia pseudomallei utilizes its BipD protein to hijack the host KLHL9/KLHL13/CUL3 E3 ubiquitin ligase complex, targeting IMMT and initiating mitophagy for immune evasion. The work details a previously unknown bacterial strategy affecting mitochondrial quality control, with implications for pathogen-host interaction research and intracellular pH regulation studies.
-
Rotigotine Hydrochloride: Mechanism, Protocols, and Antidepr
2026-06-21
Explore the unique neuropharmacological profile of Rotigotine hydrochloride, a potent dopamine D2/D3 receptor agonist, with a focus on its mechanism, protocol optimization, and emerging antidepressant properties. This article delivers actionable guidance and critical analysis for Parkinson's and depression research.
-
UBE2F-SAG–Mediated RHEB Neddylation Drives mTORC1 and Liver
2026-06-20
This study identifies RHEB as a novel neddylation substrate of the UBE2F-SAG axis, directly linking this post-translational modification to mTORC1 activation and liver tumorigenesis. These findings reveal new mechanistic insight into hepatocellular carcinoma progression and highlight potential therapeutic targets for liver disease.